» Articles » PMID: 9498471

Mycobactericidal Activity of Human Natural, Monoclonal, and Recombinant Yeast Killer Toxin-like Antibodies

Overview
Journal J Infect Dis
Date 1998 Mar 14
PMID 9498471
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Human natural (KTAb), murine monoclonal (KTMAb), and single-chain recombinant (KTScFv) candidacidal antibodies representing the internal image of a killer toxin from the yeast Pichia anomala (KT), characterized by a wide spectrum of antibiotic activity, exerted a lethal effect against a KT-sensitive multidrug-resistant isolate of Mycobacterium tuberculosis. KTMAb and KTScFv were produced by the hybridoma and DNA technologies, respectively, from the spleen lymphocytes of animals immunized with the idiotype of a KT-neutralizing MAb (MAb KT4), while KTAb were purified against MAb KT4 from the vaginal fluid of women infected with Candida albicans cells bearing an idiotype-like KT cell wall receptor. Mycobactericidal activity was related to the binding of KTAb, KTMAb, and KTScFv to the cell surface of KT-sensitive bacterial cells and was prevented by specific absorption of KT-like antibodies onto MAb KT4. These data identify a novel potentially useful immunotherapeutic approach to tuberculosis.

Citing Articles

Antibodies and tuberculosis.

Jacobs A, Mongkolsapaya J, Screaton G, McShane H, Wilkinson R Tuberculosis (Edinb). 2016; 101:102-113.

PMID: 27865379 PMC: 5120988. DOI: 10.1016/j.tube.2016.08.001.


B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Achkar J, Chan J, Casadevall A Immunol Rev. 2015; 264(1):167-81.

PMID: 25703559 PMC: 4629253. DOI: 10.1111/imr.12276.


Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Achkar J, Chan J, Casadevall A Cold Spring Harb Perspect Med. 2014; 5(3):a018432.

PMID: 25301934 PMC: 4355258. DOI: 10.1101/cshperspect.a018432.


Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Achkar J, Casadevall A Cell Host Microbe. 2013; 13(3):250-62.

PMID: 23498951 PMC: 3759397. DOI: 10.1016/j.chom.2013.02.009.


Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

Polonelli L, Ponton J, Elguezabal N, Moragues M, Casoli C, Pilotti E PLoS One. 2008; 3(6):e2371.

PMID: 18545659 PMC: 2396520. DOI: 10.1371/journal.pone.0002371.